๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carcinoembryonic antigen as a target for cancer vaccines

โœ Scribed by James W. Hodge; J. Schlom


Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
209 KB
Volume
43
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Carcinoembryonic antigen in breast cance
โœ Robert E. Myers; Donald J. Sutherland; James W. Meakin; John A. Kellen; Dina G. ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB ๐Ÿ‘ 2 views

Carcinoembryonic antigen (CEA) levels were determined in 742 postoperative patients with breast cancer. Within this group the percentage of elevated (24.0 ng/ml) assays increased with UICC clinical stage and was 14.8% (12/81), 23.7% (27/114), 73.1% (190/260) and 20.0% (49/245) for stages I, 11, 111,

Carcinoembryonic antigen (CEA) as progno
โœ Elias Alsabti ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB

## ELIAS ALSABTI, MD Radioimmunoassay for serum carcinoembryonic antigen (CEA) was performed in 49 colonic cancer patients. The test results were positive in 42 patients (85.7%) in whom tumor was present at the time of assay. Preoperatively, CEA level suggested the extent and the prognosis of the

Carcinoembryonic antigen (CEA): Its role
โœ Paul H. Sugarbaker; William D. Bloomer; Ellen D. Corbett; John T. Chaffey ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 217 KB ๐Ÿ‘ 2 views

Serial CEA radioimmunoassays have been performed on patients receiving radiation therapy preoperatively or as treatment of recurrent or metastatic colorectal cancer. Pretreatment circulating CEA titers which were elevated showed a significant decrease with accumulating doses of irradiation, indicati

Carcinoembryonic antigen and interferon
โœ Yoav Horn; Dalia Hacohen; Jacob L. Zeidman; Natalio Walach; Sally Sharf; Adi Hel ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval